Kinetic biopharmaceutical studies of a new paracetamol–glucosamine analgetic drug
Abstract
Background: Intercomponent drug interactions could play important role for drug release, membrane permeability and membranotropic action. Therefore, newly developed drugs need for checking their biopharmaceutical characteristics. A new analgetic drug based on paracetamol (Actimask® Acetaminoprofen) and a hepatoprotector N-acetyl-D-glucosamine has been developed, with increased safety and potentiation of the analgesic effect (Ruban O., 2022). Multibilayer lipid membranes were chosen as promising testing medium due to their proved appropriation and sensitivity for study multi-compound drug-membrane interactions. It is the basis for a kinetic approach allowing elucidation of biopharmaceutical interactions in model membrane medium.
Objectives: Revealing changes of paracetamol release and membrane penetration in the new paracetamol-glucosamine analgetic drug as well as estimation the rationale of the approach developed to trace biopharmaceutical interactions in model membrane medium.
Materials and Methods: L-a-dimyristoyl phosphatidylcholine (DMPC) multibilayer membrane was used as a model biomimetic testing medium. Differential scanning calorimetry (DSC) was applicated to trace kinetics of drug-membrane interactions.
Results: Gelatin as a part of Actimask® increased the characteristic time of paracetamol diffusion about threefold, but it had no pronounced effect on the equilibrium paracetamol penetration into the membrane. Sole glucosamine manifested no membranotropic effect under the experimental conditions, however, in combination with gelatin, it sufficiently reduced equilibrium paracetamol penetration while paracetamol diffusion remained within the experimental error. The full drug formulation increased membrantoropic effect by 34 % in compared with sole paracetamol.
Conclusions: Glucosamine and gelatin can affect both kinetic and equilibrium parameters of paracetamol-membrane interactions, while the full set of the drug components is able to increase the effect which correlates well with the previously established enhancement of analgetic effect of the drugs. The approach developed allows accurate tracing of drug release and membrane penetration depending on a set of drug components. Generally, the results obtained prove the rationale of applying the approach to pre-clinical drug examination.
Downloads
References
Ruban O, Zupanets I, Kolisnyk T, Shebeko S, Vashchenko O, Zimin S, et al. Pharmacological and biopharmaceutical studies of paracetamol and N-acetyl-D-glucosamine combination as an analgetic drug. ScienceRise: Pharm. Sci. 2022;35(1):28–36. https://doi.org/10.15587/2519-4852.2022.253474
Jackson K, Young D, Pant S. Drug-excipient interactions and their affect on absorption. Pharmaceutical Science & Technology Today. 2000;3(10):336–45. https://doi.org/10.1016/s1461-5347(00)00301-1
Narang AS, Boddu SHS. Excipient applications in formulation design and drug delivery. In: Narang AS, Boddu SHS, editors. Excipient applications in formulation design and drug delivery. Springer International Publishing Switzerland; 2015. Chapt. 1. p. 1–10. http://doi.org/10.1007/978-3-319-20206-8_1
Gorain B, Choudhury H, Pandey M, Madheswaran T, Kesharwani P, Tekade RK. Drug-excipient interaction and incompatibilities. In: Rakesh K, editor. Dosage form design parameters. Vol. II. Advances in pharmaceutical product development and research. Academic Press; 2018. p. 363–402. https://doi.org/10.1016/B978-0-12-814421-3.00011-7
Bharate SS, Bharate SB, Bajaj AN. Interactions and incompatibilities of pharmaceutical excipients with active pharmaceutical ingredients: a comprehensive review. J Excipients Food Chem. 2010;1(3):3–27.
Balasubramaniam J, Bindu K, Rao VU, Ray D, Haldar R, Brzeczko AW. Effect of superdisintegrants on dissolution of cationic drugs. Dissol. Technol. 2008;15(2):18–25. https://doi.org/10.14227/DT150208P18
Kolisnyk T, Vashchenko O, Ruban O, Fil N, Slipchenko G. Assessing compatibility of excipients selected for sustained release formulation of bilberry leaf extract. Braz J Pharm Sci. 2022;58. https://doi.org/10.1590/s2175-97902022e19753
Lichtenberger LM, Barron M, Marathi U. Association of phosphatidylcholine and NSAIDS as a novel strategy to reduce gastrointestinal toxicity. Drugs Today. 2009;45(12):877–90. https://doi.org/1396674/dot.2009.45.12.1441075
Orme M. Drug absorption in the gut. Br J Anaesth. 1984;56:59–67. https://doi.org/10.1093/bja/56.1.59
Seydel JK, Wiese M. Drug-membrane interactions: analysis, drug distribution, modeling. In: Mannhold R, Kubinyi H, Folkers G, editors. Methods and Principles in Medicinal Chemistry. Vol. 15. Weinheim: Wiley-VCH Verlag GmbH; 2002. 349 p.
Vashchenko OV. Individual and joint interactions of components of medicinal products with model lipid membranes [dissertation]. D. Sc. thesis. Kharkiv; 2020. 363 p. (in Ukrainian) Available from: https://rbecs.karazin.ua/wp-content/uploads/2018/dis/dis_Vashchenko.pdf
Lucio M, Lima J, Reis S. Drug-membrane interactions: significance for medicinal chemistry. Curr. Med. Chem. 2010;17:1795–809. https://doi.org/10.2174/092986710791111233
Lopes LB, Scarpa MV, Pereira NL, de Oliveira LC, Oliveira AG. Interaction of sodium diclofenac with freeze-dried soya phosphatidylcholine and unilamellar liposomes. Rev Bras Cienc Farm. 2006;42(4):497–504. https://doi.org/10.1590/S1516-93322006000400004
Kyrikou I, Hadjikakou SK, Kovala-Demertzi D, Viras K, Mavromoustakos T. Effects of non-steroid anti-inflammatory drugs in membrane bilayers. Chem Phys Lipids. 2004;132(2):157–69. https://doi.org/10.1016/j.chemphyslip.2004.06.005
Sun S, Sendecki AM, Pullanchery S, Huang D, Yang T, Cremer PS. Multistep Interactions between ibuprofen and lipid membranes. Langmuir. 2018;34(36):10782–92. https://doi.org/10.1021/acs.langmuir.8b01878
Panicker L, Sharma VK, Datta G, Deniz KU, Parvathanathan PS, Ramanathan KV, et al. Interaction of aspirin with DPPC in the lyotropic, DPPC-aspirin-H2O/D2O membrane. Mol Cryst Liq Cryst. 1995;260(1):611–21. https://doi.org/10.1080/10587259508038734
Pereira-Leite C, Nunes C, Reis S. Interaction of nonsteroidal anti-inflammatory drugs with membranes: in vitro assessment and relevance for their biological actions. Progr Lipid Res. 2013;52(4):571–84. https://doi.org/10.1016/j.plipres.2013.08.003
Flaten GE, Luthman K, Vasskog T, Brandl M. Drug permeability across a phospholipid vesicle-based barrier: 4. The effect of tensides, co-solvents and pH changes on barrier integrity and on drug permeability. Eur J Pharm Sci. 2008;34(2–3):173–80. https://doi.org/10.1016/j.ejps.2008.04.001
Lee CK, Uchida T, Kitagawa K, Yagi A, Kim NS, Goto S. Relatioship between lipophylicity and skin permeability of various drugs form an ethanol/water/lauric acid system. Biol Pharm Bull. 1994;17(10):1421–4. https://doi.org/10.1248/bpb.17.1421
Vashchenko OV, Kasian NA, Budіanska LV. Comparative effects of stearic acid, calcium and magnesium stearates as dopants in model lipid membranes. Funct Mater. 2018;25(2):300–7. https://doi.org/10.15407/FM25.02.300
Krasnikova AO, Vashchenko OV, Kasian NA, Iermak IuL, Markevich MA. Thermodynamical parameters of phase transitions in model lipid membranes as a marker of membranotropic effects of antibiotics in generic drugs. Biophysical Bulletin. 2014;32(2):27–38. Available from: https://periodicals.karazin.ua/biophysvisnyk/article/view/1589/1332 (In Russian)
Bottner M, Winter R. Influence of the local anesthetic tetracaine on the phase behavior and the thermodynamic properties of phospholipid bilayers. Biophys J. 1993;65(5):2041–6. https://doi.org/10.1016/S0006-3495(93)81254-2
Toyran N, Severcan F. The effect of magnesium ions on vitamin D2-phospholipid model membrane interactions in the presence of different buffer media. Talanta. 2000;53(1):23–7. https://doi.org/10.1016/S0039-9140(00)00378-7
Toyran N, Severcan F. Infrared spectroscopic studies on the dipalmitoyl phosphatidylcholine bilayer interactions with calcium phosphate: effect of vitamin D2. Spectroscopy. 2002;16(3):399–408. https://doi.org/10.1155/2002/381692
Toyran N, Severcan F. Competitive effect of vitamin D2 and Ca2+ on phospholipid model membranes: an FTIR study. Chem Phys Lipids. 2003;123(2):165–76. https://doi.org/10.1016/s0009-3084(02)00194-9
Ricci M, Oliva R, Del Vecchio P, Paolantoni M, Morresi A, Sassi P. DMSO-induced perturbation of thermotropic properties of cholesterol-containing DPPC liposomes. Biochim Biophys Acta – Biomembranes. 2016;1858(12):3024–31. https://doi.org/10.1016/j.bbamem.2016.09.012
Vashchenko OV, Budianska LV. Joint action of pharmaceuticals in model lipid membranes: calorimetric effects. Biophysical Bulletin. 2016;36(2):11–8. https://doi.org/10.26565/2075-3810-2016-36-02 (In Russian)
Johansson ME, Nicklasson M. Investigation of the film formation of magnesium stearate by applying a flow-through dissolution technique. J Pharm Pharmacol. 1986;38(1):51–4. https://doi.org/10.1111/j.2042-7158.1986.tb04466.x
Drug-biomembrane interaction studies. The application of calorimetric techniques. Pignatello R, editor. New Delhi: Woodhead Publishing; 2013. 436 р.
Mavromoustakos TM. The use of differential scanning calorimetry to study drug-membrane interactions. In: Dopico AM, editor. Methods in Membrane Lipids. Methods in Molecular Biology™, vol. 400. Humana Press. 2007. p. 587–600. https://doi.org/10.1007/978-1-59745-519-0_39
Kasian NA, Vashchenko OV, Budianska LV, Brodskii RYe, Lisetski LN. Thermodynamics and kinetics of joint action of antiviral agent tilorone and DMSO on model lipid membranes. Biochim Biophys Acta – Biomembranes. 2019;1861(1):123–9. https://doi.org/10.1016/j.bbamem.2018.08.007
Lvov JM, Mogilevskij LJ, Fejgin LA, Györgyi S, Ronto Gy, Thompson KK, et al. Structural parameters of phosphatidylcholine bilayer membranes. Mol Cryst Liq Cryst. 1986;133(1–2):65–73. https://doi.org/10.1080/00268948608079561
Nademi Y, Iranagh SA, Pour АY, Mousavi SZ, Modarress H. Molecular dynamics simulations and free energy profile of paracetamol in DPPC and DMPC lipid bilayers. J Chem Sci. 2014;126(3):637–47. https://doi.org/10.1007/s12039-013-0556-x
Digenis GA, Sandefer EP, Page RC, Doll WJ, Gold TB, Darwazeh NB. Bioequivalence study of stressed and nonstressed hard gelatin capsules using amoxicillin as a drug marker and gamma scintigraphy to confirm time and GI location of in vivo capsule rupture. Pharm Res. 2000;17(5):572–82. https://doi.org/doi:10.1023/a:1007568900147
Meyer MC, Straughn AB, Mhatre RM, Hussain A, Shah VP, Bottom CB, et al. The effect of gelatin cross-linking on the bioequivalence of hard and soft gelatin acetaminophen capsules. Pharm Res. 2000;17(8):962–6. https://doi.org/10.1023/A:1007579221726
Koynova R, Caffrey M. Phases and phase transitions of the phosphatidylcholines. Biochim Biophys Acta – Reviews on Biomembranes. 1998;1376(1):91–145. https://doi.org/10.1016/S0304-4157(98)00006-9
Lewis RNAH, McElhaney RN. The mesomorphic phase behavior of lipid bilayers In: Yeagle PL, editor. The structure of biological membranes. 2nd ed. Boca Raton: CRC Press; 2004. p. 53–72. https://doi.org/10.1201/9781420040203
Kasian NA, Vashchenko OV, Budianska LV, Brodskii RYe, Lisetski LN. Cooperative domains in lipid membranes: size determination by calorimetry. J Therm Anal Calorim. 2019;136(2):795–801. https://doi.org/10.1007/s10973-018-7695-8
Tomassetti M, Catalani A, Rossi V, Vecchio S. Thermal analysis study of the interactions between acetaminophen and excipients in solid dosage forms and in some binary mixtures. J Pharm Biomed Anal. 2005;37(5):949–55. https://doi.org/10.1016/j.jpba.2004.10.008
Patel S, Patel M, Kulkarni M, Patel MS. DE-INTERACT: A machine-learning-based predictive tool for the drug-excipient interaction study during product development—Validation through paracetamol and vanillin as a case study. Int J Pharm. 2023;637:122839. https://doi.org/10.1016/j.ijpharm.2023.122839
Chayka LA, Povolotskaya VA, Lisetskiy LN, Panikarskaya VD, Kostrova AA. Vliyanie paratsetamola i ego kombinatsiy na termodinamicheskie harakteristiki membrannyih struktur [Effect of paracetamol and its combinations on thermodynamic characteristics of membrane structures]. Pharmacom. 1995;7:20–2 (In Russian)
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
